CVX.V
CEMATRIX Corporation [CVX.V] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CVX.V Stock Summary
Top 10 Correlated ETFs
CVX.V
Top 10 Correlated Stocks
CVX.V
In the News
CVX.V Financial details
Company Rating
Buy
Market Cap
26.88M
Income
-5.02M
Revenue
31.06M
Book val./share
0.2
Cash/share
0.07
Dividend
-
Dividend %
-
Employees
63
Optionable
No
Shortable
Yes
Earnings
08 Aug 2023
P/E
-5.34
Forward P/E
-
PEG
-0.4
P/S
0.87
P/B
1.02
P/C
2.86
P/FCF
-5.75
Quick Ratio
1.69
Current Ratio
1.84
Debt / Equity
0.3
LT Debt / Equity
0.1
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
157.76%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
8.98%
Revenue last 5Y
10.56%
Revenue Q/Q
-13.49%
EPS Q/Q
34.41%
-
-
-
-
SMA20
-9.09%
SMA50
17.65%
SMA100
-9.09%
Inst Own
-
Inst Trans
-
ROA
-13%
ROE
-18%
ROC
-0.15%
Gross Margin
11%
Oper. Margin
-14%
Profit Margin
-16%
Payout
-
Shs Outstand
134.38M
Shs Float
115.95M
-
-
-
-
Target Price
-
52W Range
0.14-0.28
52W High
-
52W Low
-
RSI
46.69
Rel Volume
0.11
Avg Volume
62.43K
Volume
7K
Perf Week
0%
Perf Month
11.11%
Perf Quarter
-9.09%
Perf Half Y
25%
-
-
-
-
Beta
0.775429
-
-
Volatility
0.01%, 0.01%
Prev Close
0%
Price
0.2
Change
-4.76%
CVX.V Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.44 | 0.45 | 0.43 | 0.2 | 0.22 | |
| Net income per share | -0.03 | -0.01 | -0.16 | -0.02 | -0.04 | |
| Operating cash flow per share | -0.03 | 0.01 | 0.03 | -0.01 | -0.02 | |
| Free cash flow per share | -0.03 | -0.01 | 0.02 | -0.01 | -0.04 | |
| Cash per share | 0.02 | 0.02 | 0.04 | 0.17 | 0.08 | |
| Book value per share | 0.12 | 0.15 | 0.01 | 0.27 | 0.21 | |
| Tangible book value per share | -0.06 | -0.01 | -0.11 | 0.22 | 0.16 | |
| Share holders equity per share | 0.12 | 0.15 | 0.01 | 0.27 | 0.21 | |
| Interest debt per share | 0.29 | 0.35 | 0.28 | 0.08 | 0.07 | |
| Market cap | 7.17M | 16.89M | 44.68M | 38.08M | 29.47M | |
| Enterprise value | 17.07M | 31.78M | 57.29M | 26.53M | 26.36M | |
| P/E ratio | -6.57 | -66.57 | -4.57 | -20.53 | -5.3 | |
| Price to sales ratio | 0.41 | 0.75 | 1.68 | 1.68 | 1.02 | |
| POCF ratio | -6.52 | 67.07 | 26.9 | -45.71 | -9.19 | |
| PFCF ratio | -5.85 | -36.67 | 29.09 | -25.27 | -5.79 | |
| P/B Ratio | 1.51 | 2.23 | 65.76 | 1.21 | 1.06 | |
| PTB ratio | 1.51 | 2.23 | 65.76 | 1.21 | 1.06 | |
| EV to sales | 0.97 | 1.41 | 2.16 | 1.17 | 0.91 | |
| Enterprise value over EBITDA | 33.87 | 11.61 | 33.69 | -26.8 | -8.17 | |
| EV to operating cash flow | -15.5 | 126.22 | 34.49 | -31.85 | -8.22 | |
| EV to free cash flow | -13.92 | -69.02 | 37.31 | -17.6 | -5.18 | |
| Earnings yield | -0.15 | -0.02 | -0.22 | -0.05 | -0.19 | |
| Free cash flow yield | -0.17 | -0.03 | 0.03 | -0.04 | -0.17 | |
| Debt to equity | 2.22 | 2.08 | 22.21 | 0.27 | 0.27 | |
| Debt to assets | 0.52 | 0.52 | 0.52 | 0.19 | 0.19 | |
| Net debt to EBITDA | 19.63 | 5.44 | 7.42 | 11.67 | 0.96 | |
| Current ratio | 0.98 | 0.81 | 0.51 | 5.67 | 1.92 | |
| Interest coverage | 0.75 | 0.65 | -0.44 | -2.65 | -4.67 | |
| Income quality | 1.01 | -0.99 | -0.17 | 0.45 | 0.58 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.12 | 0.18 | 0.25 | 0.22 | 0.27 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.36 | 0.27 | 0.25 | 0.13 | 0.15 | |
| Capex to operating cash flow | 0.11 | -2.83 | -0.08 | 0.81 | 0.59 | |
| Capex to revenue | -0.01 | -0.03 | 0 | -0.03 | -0.06 | |
| Capex to depreciation | -0.13 | -0.4 | -0.05 | -0.27 | -1.01 | |
| Stock based compensation to revenue | 0 | 0.02 | 0 | 0.01 | 0.02 | |
| Graham number | 0.27 | 0.13 | 0.2 | 0.31 | 0.44 | |
| ROIC | 0.03 | 0.03 | -0.04 | -1.09 | -0.31 | |
| Return on tangible assets | -0.08 | -0.01 | -0.45 | -0.05 | -0.16 | |
| Graham Net | -0.27 | -0.36 | -0.36 | 0.1 | 0.03 | |
| Working capital | -130.03K | -1.57M | -7.77M | 21.78M | 9.4M | |
| Tangible asset value | -2.54M | -573.68K | -6.59M | 25.83M | 21.59M | |
| Net current asset value | -9.13M | -15.97M | -20.05M | 13.63M | 6.49M | |
| Invested capital | 2.22 | 2.08 | 22.21 | 0.27 | 0.27 | |
| Average receivables | 2.95M | 4.92M | 4.54M | 4.62M | 6.12M | |
| Average payables | 857.28K | 1.51M | 1.4M | 1.74M | 3.37M | |
| Average inventory | 407.56K | 515.61K | 676.64K | 705.11K | 864K | |
| Days sales outstanding | 105.73 | 76.86 | 59.49 | 79.31 | 92.35 | |
| Days payables outstanding | 38.36 | 35.48 | 20.21 | 45.26 | 60.82 | |
| Days of inventory on hand | 10.22 | 14.38 | 12.06 | 14.01 | 13.92 | |
| Receivables turnover | 3.45 | 4.75 | 6.14 | 4.6 | 3.95 | |
| Payables turnover | 9.52 | 10.29 | 18.06 | 8.07 | 6 | |
| Inventory turnover | 35.7 | 25.37 | 30.26 | 26.05 | 26.22 | |
| ROE | -0.23 | -0.03 | -14.39 | -0.06 | -0.2 | |
| Capex per share | 0 | -0.01 | 0 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q1
| Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.04 | 0.03 | 0.09 | 0.06 | 0.05 | |
| Net income per share | -0.02 | -0.01 | 0 | -0.01 | -0.01 | |
| Operating cash flow per share | -0.01 | -0.01 | 0 | 0 | 0 | |
| Free cash flow per share | -0.01 | -0.02 | -0.01 | 0 | -0.01 | |
| Cash per share | 0.14 | 0.1 | 0.09 | 0.08 | 0.07 | |
| Book value per share | 0.22 | 0.21 | 0.22 | 0.21 | 0.2 | |
| Tangible book value per share | 0.18 | 0.17 | 0.17 | 0.16 | 0.2 | |
| Share holders equity per share | 0.22 | 0.21 | 0.22 | 0.21 | 0.2 | |
| Interest debt per share | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Market cap | 33.48M | 26.79M | 24.11M | 29.47M | 24.12M | |
| Enterprise value | 23.59M | 21.36M | 20.09M | 26.36M | 22.29M | |
| P/E ratio | -3.79 | -4.14 | -12.43 | -5.91 | -3.61 | |
| Price to sales ratio | 6.54 | 6.66 | 2.09 | 3.55 | 3.36 | |
| POCF ratio | -47.84 | -13.36 | -44.4 | 654.84 | -101.34 | |
| PFCF ratio | -27.22 | -10.9 | -28.2 | -54.37 | -29.49 | |
| P/B Ratio | 1.13 | 0.95 | 0.83 | 1.06 | 0.92 | |
| PTB ratio | 1.13 | 0.95 | 0.83 | 1.06 | 0.92 | |
| EV to sales | 4.6 | 5.31 | 1.74 | 3.18 | 3.1 | |
| Enterprise value over EBITDA | -17.08 | -12.5 | 28.53 | -29.79 | -35.33 | |
| EV to operating cash flow | -33.69 | -10.65 | -36.99 | 585.79 | -93.68 | |
| EV to free cash flow | -19.18 | -8.69 | -23.49 | -48.64 | -27.26 | |
| Earnings yield | -0.07 | -0.06 | -0.02 | -0.04 | -0.07 | |
| Free cash flow yield | -0.04 | -0.09 | -0.04 | -0.02 | -0.03 | |
| Debt to equity | 0.28 | 0.3 | 0.28 | 0.27 | 0.3 | |
| Debt to assets | 0.2 | 0.21 | 0.19 | 0.19 | 0.2 | |
| Net debt to EBITDA | 7.17 | 3.18 | -5.71 | 3.51 | 2.89 | |
| Current ratio | 5.03 | 2.71 | 2.05 | 1.92 | 1.84 | |
| Interest coverage | -7.21 | -7.8 | 0.78 | -4.4 | -4.69 | |
| Income quality | 0.32 | 1.24 | 1.12 | -0.04 | 0.14 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.37 | 0.04 | 0.18 | 0.22 | 0.29 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.13 | 0.15 | 0.14 | 0.15 | 0.16 | |
| Capex to operating cash flow | 0.76 | 0.23 | 0.57 | -13.04 | 2.44 | |
| Capex to revenue | -0.1 | -0.11 | -0.03 | -0.07 | -0.08 | |
| Capex to depreciation | -1.2 | -1 | -0.69 | -1.16 | -1.04 | |
| Stock based compensation to revenue | 0.03 | 0.04 | 0.01 | 0.02 | 0.02 | |
| Graham number | 0.29 | 0.24 | 0.13 | 0.21 | 0.23 | |
| ROIC | -0.49 | -0.15 | 0.05 | -0.06 | -0.08 | |
| Return on tangible assets | -0.06 | -0.05 | -0.01 | -0.04 | -0.05 | |
| Graham Net | 0.07 | 0.04 | 0.03 | 0.03 | 0.02 | |
| Working capital | 19.02M | 11.96M | 11.67M | 9.4M | 7.65M | |
| Tangible asset value | 23.86M | 22.28M | 22.66M | 21.59M | 20.04M | |
| Net current asset value | 10.95M | 7.64M | 7.4M | 6.49M | 4.75M | |
| Invested capital | 0.28 | 0.3 | 0.28 | 0.27 | 0.3 | |
| Average receivables | 0 | 4.12M | 6.74M | 8.45M | 6.52M | |
| Average payables | 0 | 1.82M | 3.03M | 4.47M | 3.76M | |
| Average inventory | 0 | 781.5K | 837.5K | 901.5K | 998.5K | |
| Days sales outstanding | 75.78 | 87.67 | 74.52 | 79.55 | 71.55 | |
| Days payables outstanding | 36.6 | 33.69 | 43.74 | 50.36 | 43.57 | |
| Days of inventory on hand | 11.81 | 19.48 | 7.65 | 11.53 | 13.8 | |
| Receivables turnover | 1.19 | 1.03 | 1.21 | 1.13 | 1.26 | |
| Payables turnover | 2.46 | 2.67 | 2.06 | 1.79 | 2.07 | |
| Inventory turnover | 7.62 | 4.62 | 11.77 | 7.81 | 6.52 | |
| ROE | -0.07 | -0.06 | -0.02 | -0.04 | -0.06 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
CVX.V Frequently Asked Questions
What is CEMATRIX Corporation stock symbol ?
CEMATRIX Corporation is a CA stock , located in Calgary of Ab and trading under the symbol CVX.V
What is CEMATRIX Corporation stock quote today ?
CEMATRIX Corporation stock price is $0.2 today.
Is CEMATRIX Corporation stock public?
Yes, CEMATRIX Corporation is a publicly traded company.
Company Profile
- Volume Average 62.43K
- Market Capitalization 26.88M
- Employee 63
- CEO Mr. Jeffery Norman Kendrick C.A., CPA
- Headquarters Calgary,AB,CA
- IPO Date 2007-10-25
-
Website
https://www.cematrix.com 
CEMATRIX Corporation manufactures and supplies cellular concrete products for various applications in Canada and the United States. Its cellular concrete products are used in lightweight backfill for MSE walls, bridge approach backfill, roadways and runways, and slope stabilization; insulation materials for oil and gas facility slabs, roadways, shallow utilities, and contaminated site remediation; and tunnel grout, annular pipe grout, pipe abandonment, and flowable fills applications. CEMATRIX Corporation is based in Calgary, Canada.
